• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • 0 CME Hours
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
#Grand Rounds

Expectant Management vs Induction at 39 Weeks: Is There a Difference in Cost?

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • Einerson et al. (Obstetrics & Gynecology, 2020) compared the actual health-system costs of elective labor induction at 39 weeks vs expectant management among patients enrolled at the ARRIVE Utah study sites (see ‘Related ObG Topics’ below for further information on the ARRIVE trial)

METHODS:

  • Economic analysis
  • Participants
    • Low-risk, nulliparous women enrolled in the ARRIVE trial
  • Study design
    • Direct health system costs of maternal and neonatal care were measured using advanced costing analytics from the time of randomization (38 weeks of gestation) until exit from the study (up to 8 weeks postpartum)
    • Costs in each randomization arm were compared | Costs were reported as the relative cost of induction compared with expectant management
    • With a fixed sample size, this study was powered to detect a ≥7.3% difference in overall costs
  • Primary outcome
    • Relative direct health care costs of maternal and neonatal care from a health system perspective
  • Secondary outcomes
    • Costs of each phase of maternal and neonatal care

RESULTS:

  • 1,201 women had cost data available
  • Total cost of induction was no different than expectant management
    • Mean difference: +4.7% (95% CI, −2.1% to +12.0%; P =0.18)
  • The following were found among patients in the induction arm
    • Maternal outpatient antenatal care costs: 47.0% lower (95% CI −58.3% to −32.6%; P < 0.001)
    • Maternal inpatient intrapartum and delivery care costs: 16.9% higher (95% CI, +5.5% to +29.5%; P = 0.003)
  • There was no difference between arms for the following
    • Maternal inpatient postpartum care
    • Maternal outpatient care after discharge
    • Neonatal hospital care
    • Neonatal care after discharge

CONCLUSION:

  • The total cost of elective induction of labor at 39 weeks was not significantly different from that of expectant management
  • The authors state that

This analysis challenges the longstanding assumption that elective induction of labor at term leads to significant cost escalation

Learn More – Primary Sources:

Cost of Elective Labor Induction Compared With Expectant Management in Nulliparous Women

Now You Can Get ObG Clinical Research Summaries Direct to Your Phone, with ObGFirst

ObGFirst® – Try It Free! »

image_pdfFavoriteLoadingFavorite
< Previous
All #Grand Rounds Posts
Next >

Related ObG Topics:

The ARRIVE Trial and Professional Guidance: Elective 39 Week Induction to Reduce the Risk of Cesarean Section
Does Elective Induction of Labor at 39 Weeks Gestation Lead to Improved Maternal and Newborn Outcomes?
Low-Risk Multiparous Women: Induction of Labor at 39 Weeks or Expectant Management?
Is Elective Induction Linked to Lower Risk of C-section?

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • #Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

ObG Library

  • Hysteroscopy
  • Fertility
  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Log In to ObG First

Please log in to access OBGFirst and the 2T Ultrasound Atlas

Password Trouble?

Sign Up for ObGFirst

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!

ObG First Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site